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ABSTRACT The association of an anti-dinitrophenyl monoclonal antibody and its Fab fragment with supported phospholipid
monolayers composed of a mixture of dipalmitoylphosphatidylcholine and dinitrophenyl-conjugated dipalmitoylphos-
phatidylethanolamine has been characterized with total internal reflection fluorescence microscopy. The surface densities of
bound antibodies were measured as a function of the antibody and Fab solution concentrations, and as a function of the
solution concentration of dinitrophenylglycine. The apparent association constant of Fab fragments with surface-associated
haptens was -10-fold lower than the association constant for haptens in solution, and the apparent surface association
constant for intact antibodies was only -10-fold higher than the constant for Fab fragments. Data analysis with simple
theoretical models indicated that, at most antibody surface densities, 50-90% of membrane-associated intact antibodies
were attached to the surface by two antigen binding sites.
INTRODUCTION
The association of antibodies with cell surfaces is a key
molecular event in antibody-mediated immune mecha-
nisms such as phagocytosis, B cell activation, and antibody-
dependent cell-mediated cytotoxicity. The relationship of
the thermodynamic and kinetic aspects of antibody-
membrane association, the translational and rotational
mobilities of membrane-bound antibodies, the interac-
tions of membrane-bound antibodies with other cell
surface molecules or circulating molecules, and the confor-
mation of membrane-associated antibodies to these im-
mune functions is not yet well understood. The details of
the association of antibodies with surfaces are also of
importance in the development and application of biosen-
sors and immunodiagnostic devices. This work addresses
the relationship between antibody-hapten interactions in
solution and on surfaces, and the role of antibody biva-
lency in surface binding.
One method of investigating the interaction of antibod-
ies with membranelike surfaces is to use phospholipid
monolayers or bilayers deposited on planar substrates
(Thompson et al., 1988; McConnell et al., 1986). Previous
work has demonstrated that hapten-specific monoclonal
antibodies bind to supported phospholipid monolayers
and bilayers that contain hapten-conjugated phospholip-
ids; that the arrangements and mobilities of the bound
antibodies are sensitive functions of the physical and
chemical properties of the supported phospholipid films,
of the structure and density of the bound antibodies, and
of the solution properties; and that immunological cells
containing surface receptors for antibodies specifically
bind to and metabolically respond to the supported
phospholipid films in the presence of hapten-specific
antibodies (Timbs and Thompson, 1990; Wright et al.,
1988; Tamm, 1988a; Subramaniam et al., 1986; Uzgiris,
1986; Hafeman et al., 1981).
A technique for quantitatively characterizing the asso-
ciation of fluorescently-labeled molecules with sites on
planar surfaces is total internal reflection fluorescence
microscopy (TIRFM; Axelrod et al., 1984). In this
technique, the thin evanescent field created by a totally
internally reflected excitation source selectively excites
surface-bound fluorescent molecules. TIRFM has been
used to examine the association of a variety of biochemi-
cal ligands with specific surface sites (Poglitsch and
Thompson, 1990; Sui et al., 1988; Hlady et al., 1988,
1989; Darst et al., 1988).
TIRFM and supported phospholipid monolayers used
in conjunction provide a unique model system amenable
to the investigation of protein binding at surfaces. In this
work, TIRFM has been applied to the association of a
monoclonal anti-dinitrophenyl (DNP) antibody and its
Fab fragment with supported phospholipid monolayers
containing DNP-conjugated phospholipids. Surface bind-
ing curves were obtained as a function of the antibody
solution concentrations and as a function of the concentra-
tion of competing hapten in solution. In addition, the
antibody-hapten association in solution was characterized
by tryptophan fluorescence quenching. These data pro-
vide a comparison of the association constants of intact
antibodies and Fab fragments with haptens in solution
and on surfaces, and provide an estimate of the associa-
tion constant that describes the equilibrium between
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intact antibodies bound to the surface by one and two
antigen binding sites. This equilibrium is significant
because it addresses the biological importance of antibody
bivalency, and because it may be related to the transla-
tional and rotational mobilities of surface-bound antibod-
ies and, therefore, to potential interactions of surface-
bound antibodies with other surface-bound molecules.
cet, 1977; Eisen and Siskind, 1964) or of the visible
fluorescence of haptens by specific antibodies (Herron et
al., 1986; Lancet and Pecht, 1977) can be used to examine
the thermodynamic parameters of antibody-hapten asso-
ciation in solution. In the simplest model, monovalent Fab
fragments (M) and monovalent haptens (D) combine to
form complexes (MD) with association constant K,:
KJ[M][D] = [MD].
THEORETICAL BACKGROUND
Quantitative comparison of association constants for
antibodies and haptens undergoing reaction in different
states of valency (e.g., Fab fragment vs. intact) and in
different geometries (e.g., solution vs. surface) requires
assumptions for the binding mechanisms. In this work,
the data are analyzed assuming that Fab fragments react
with monovalent haptens in solution and on surfaces
according to simple bimolecular reactions, and that intact
antibodies react with monovalent haptens in solution by
two sequential bimolecular reactions.
The association of bivalent anti-hapten antibodies with
surfaces that contain an abundance of haptenic sites is
more complex. Therefore, three distinct but still simple
mechanisms for this interaction have been considered. In
model I, a ternary reaction occurs between an antibody
and two surface sites. In model II, a bimolecular reaction
first occurs between an antibody and a free-surface site,
resulting in monovalent surface attachment, and then an
isomerization occurs that results in bivalent attachment.
In model III, a bimolecular reaction first occurs between
an antibody and a free surface site, resulting in monova-
lent attachment, but then a second bimolecular reaction
occurs between the monovalently bound antibody and
another free surface site to result in bivalent attachment.
The functional forms of the binding curves for different
antibody-hapten binding valencies, geometries, and mech-
anisms are outlined in this section. These functional forms
are used with the experimental data to obtain best-fit
parameter values for the equilibrium constants in the
different binding mechanisms. The best-fit equilibrium
constants that describe the different types of antibody-
hapten interactions are then compared. Some of these
theoretical expressions have been previously described in
similar contexts (e.g., Goldstein et al., 1989; Darst et al.,
1988; Erickson et al., 1986; Dower et al., 1981; Perelson
and DeLisi, 1980; Reynolds, 1979; Dembo and Goldstein,
1978).
Monovalent antibody fragments and
monovalent haptens in solution
Quenching of the ultraviolet fluorescence of anti-DNP
antibodies by DNP-conjugated ligands (Pecht and Lan-
(1)
The total concentrations of Fab fragments [NM] and
haptens [T] equal
[NM] = [Ml + [MD]
[T] = [DI + [MD],
and the fractions
(Eqs. 1 and 2)
(2)
(3)
of bound and free Fab fragments are
[MD] Ks[D]
[NM] = 1 + KS[D]
[Ml 1
[NM] = 1 + KS[D] '
(4)
(5)
where the free hapten concentration [D] is (Eqs. 1, 2 and
3)
[D] = [K,([T] - [NM]) - 1
+ j{Ks([T] - [NM]) - 112 + 4KS[T]
. 2Ks. (6)
The fluorescence in the presence of hapten relative to the
fluorescence in the absence of hapten is (Eqs. 4 and 5)
F([T]) Qf[M] + Qb[MD] 1 - Qb/Qf
F(O) = Qf[NM] 1 + Ks[D] + Qb/Qf. (7)
where Qb and Qf are the fluorescence intensities of bound
and free Fab fragments. The best fit of an experimentally
determined fluorescence quenching curve F([T])/F(0) to
Eqs. 6 and 7 for a known [NM] yields a measure of the
free parameters K,, Qb/Qf, and F(0).
Bivalent antibodies and monovalent
haptens in solution
The association of bivalent antibodies (B) and monova-
lent haptens (D) in solution to form antibodies with one
occupied site (BD) and antibodies with two occupied sites
(BD2) is characterized by two equilibrium constants, K.,
and K,2, where
K,J[B][D] = [BD]
KA2[BD] [DI = [BD2].
(8)
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The total antibody and hapten concentrations are
[NB] = [B] + [BD] + [BD2] (10)
[T] = [D] + [BD] + 2[BD2], (11)
and the fraction of antibody binding sites that are
occupied is (Eqs. 8-10)
1/2 [BD] + [BD2] K51[D](1 + 2K54D])
[NB] 2(1 + Ksl[D] + KsIKs2[D]2) (12)
If the hapten binding sites are independent, then
Ks = '/2KsI = 2Ks2 (13)
(Cantor and Schimmel, 1981), Eq. 12 reduces to Eq. 4,
Eqs. 8-1 1 and 13 give the expression in Eq. 6 for the free
hapten concentration with [NM] = 2[NB], and the
process is analogous to that of monovalent antibodies. The
normalized fluorescence F([T])/F([O]) given by Eqs. 6
and 7 yields a measure ofK, Qb/Qf, and F(O).
Monovalent antibodies and
surface-bound haptens
The association of fluorescently-labeled antibodies with
surface-bound haptens can be examined by using evanes-
cent illumination, under which the measured fluorescence
is in the simplest case proportional to the surface density
of bound antibodies (Axelrod et al., 1984). The associa-
tion of monovalent antibody Fab fragments in solution
(M) with sites on a membrane surface (A) to form
membrane-bound antibodies (MA) is most simply charac-
terized by a single equilibrium constant Km,, where
Km,[MI[A] = [MA]. (14)
In the experiments described herein, the surface haptens
are much smaller than the Fab fragments, and the
supported monolayers contain a high molar fraction of
hapten-conjugated phospholipid, so that [A] represents
the surface density of Fab binding sites but not necessar-
ily of free haptens. The total density of antibody surface
sites [S] is
[S] = [A] + [MA]. (15)
Assuming that the surface does not significantly deplete
the solution of antibodies so that the antibody solution
concentration [M] equals the applied concentration [NM]
(see below), Eqs. 14 and 15 imply that the surface
fluorescence is given by the conventional saturation func-
tion
F([NM]) [MA] _ Kml[NM] (16)
F([oo]) [S] 1 + Km1[NM]
The best fit of the experimentally measured fluorescence
as a function of [NM ] to this functional form yields values
for the surface association constant Kmi and F[oo]. Of
particular interest is the difference between the measured
values of the equilibrium constants for haptens in solution
(K,) and membrane-associated haptens (Km,).
Bivalent antibodies and
surface-bound haptens
The association of bivalent antibodies with haptenated
planar membranes can be investigated by measuring the
evanescently excited fluorescence as a function of the
solution concentration of free bivalent antibodies. Three
simple models that include antibody bivalency are consid-
ered. In all of the models, the bivalent antibody solution
concentration [B] is assumed to equal the applied concen-
tration [NB], and the density of antibody surface sites,
which does not necessarily equal the hapten density (see
above), is denoted by [S].
In model I, the surface association is a single-step
mechanism and occurs as a ternary reaction in which
antibodies in solution (B) and two free surface sites (A)
form surface-bound antibodies (BA2) with association
constant Km2:
Km2[B][A]2 = [BA2]. (17)
The total surface site density equals
[S] = [BA2] + '/2[A], (18)
and (Eqs. 17 and 18)
F([NBs) [BA2]
F(oo) [S]
1 + 8Km2[S][NB] - A + 16Km2[S] [NB]
8Km2[S] [NB] (19)
Eq. 19 contains two free parameters, Km2[S] and F(oo); its
shape is illustrated in Fig. 1 a. The antibody solution
concentration [NB] at which the fluorescence equals
one-half the theoretical maximum is (2Km2[S])'.
In model II, the antibody surface association is a
two-step process. In the first step, which is bimolecular, an
antibody in solution combines with a surface binding site
to form an antibody bound by one antigen binding site
(BA). In the second step, which is unimolecular, the
antibody combines with an additionalfree hapten within
the surface binding site, isomerizing to form an antibody
bound by two antigen binding sites. This two-step mecha-
nism is characterized by association constants Km3 and
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(20)Km3[B] [A] = [BA];
Km4[BA] = [BA2].
The maximum antibody surface density is
[S] = [A] + [BA] + [BA2],
(21)
(22)
and (Eqs. 20-22)
F([NBI) [BA] + [BA2] Km3(1 + Km4)[NB] (23)
F(o) [S] 1 + Km3(l + Km4)[NB]
Eq. 23 has the shape of a conventional saturation curve
with two free parameters, F(oo) and Km3(1 + Km4) (Fig.
1 a). The apparent association constant ranges from Km3
(when Km4 << 1, monovalent binding) to Km3Km4 (when
Km4 >> 1, bivalent binding). The concentration [NB] at
which the fluorescence equals one-half the maximum
value is [Km3(1 + Ki4)] -. Comparison of data obtained
for monovalent (Eq. 16) and bivalent (Eq. 23) antibodies
provides an estimate of Km4 with the assumption that
Kml = Km3.
In model III, the reaction also occurs in two steps. The
first step is identical to that of model II. However, in the
second step the antibody undergoes a bimolecular reac-
tion in which an antibody bound to the surface by one
antigen binding region combines with an additional
surface binding site to form an antibody bound by two
sites. Eq. 20 and
Km5[BA] [A] = [BA2]
[S] = '/2[A] + '/2[BA] + [BA2]
imply that
F([NB]) [BA] + [BA2]
F(oo) = 2[S]
= [I + 8Kms[S]Km3[NB] - (Km3[NB] )2
+ (Km3[NB] - 1)
* V(Km3[NB] + 1)2 + 16Km5[S]Km3[NB]]
+ 16Km5[S]Km3[NB]1.0
FIGURE 1 Theoretical shape of surface fluorescence as a function of
bivalent antibody solution concentration. The fluorescence as a function
of the antibody solution concentration monotonically increases: model I,
Eq. 19, (a, -----); model II, Eq. 23, (a, ); model III, Eq. 26 (b). The
fraction of bound antibodies that are attached by two sites equals one in
model I but depends on the association constants in models II (c, -----)
and III (c, ); curves are plotted for Km4 and 2Km4[S] equal to 0.1,
1.0, 10, and 100.
(24)
(25)
(26)
The fluorescence as a function of the antibody solution
concentration contains three free parameters, Km3, Km5[S],
and F(oo) (Fig. 1 b). When Km5[S] is small, the process is
that of monovalent surface association. Eq. 26 reduces to
Eq. 16 with Km, = Km3 and [NM] = [NB], Eq. 26 reduces
to Eq. 23 with Km4 = 0, and the antibody concentration at
which the fluorescence is half maximal is K -. When
Km [S] is large, the experimentally accessible values of
[NB] are much less than K-, Eq. 26 reduces to Eq. 19
with Km2 = Km3Km5 (multiplied by one-half), and the
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antibody concentration at which the fluorescence equals
one-half the experimental (not theoretical) maximum is
(2Km3Km5[S])-1
In models II and III, the first association constant Km3
(Eq. 20) describes the initial antibody-surface association
and can be directly compared to the Fab surface associa-
tion constant Km, (Eq. 14); differences in magnitude
suggest that the presence of the second antibody binding
site and/or the Fc region influences the initial surface
association. The second association constant Km4 (Eq. 21)
or Km5 (Eq. 24) describes the ratio of surface-bound
antibodies that are attached to the surface by one or two
antigen binding sites:
[BA2]
= [BA] + [BA2] (27)
In model II, this ratio is independent of the antibody
surface density and equals (Eq. 21)
f2= l Km4 (28)
1+Km4
In model III, the ratio f2 depends on the fraction of
antibody surface sites that are occupied,.f, where
fo = 1 -1/2([A / [SI), (29)
and Eqs. 24, 27, and 29 imply that
f2 = 1 + 2Km[S](1-fo) (30)
For most antibody surface densities, very few of the bound
antibodies are attached by two sites when Km5[S] is low,
and most are bivalently bound when Km5[S] is high.
However, for very large antibody solution concentrations
and surface coverages, all bound antibodies are attached
by only one antigen binding site. The fractions of bound
antibodies that are attached by two sites in models II and
III are illustrated in Fig. 1 c. In model I,f2 = 1.
Inhibition of monovalent antibody
surface binding by soluble hapten
Previous work has shown that the binding of anti-DNP
antibodies to supported planar membranes containing
DNP-conjugated phospholipids is blocked by DNP-
glycine (Wright et al., 1988). Experimentally, the evanes-
cently excited fluorescence arising from bound antibodies
may be measured as a function of the total concentration
of hapten in solution [T] and is relative to the fluorescence
in the absence of soluble hapten. If the volume/surface
ratio is large enough so that the surface does not deplete
the solution of antibodies, Eqs. 1, 2, 14, and 15 imply that
F([T]) [MA] 1 + Km,[NM]
F(0) [MA]O 1 + Km,[NM] + Ks[D]'
(31)
where [MA]. is the antibody surface density in the
absence of soluble hapten. In the simplest case, the free
hapten concentration [D] is approximately equal to the
total hapten concentration [T], the best fit of an experi-
mentally measured curve to the form of Eq. 31 with
[DI = [T] yields a value for K,/(I + Km, [NM]), and a set
of curves for different antibody solution concentrations
[NM] provides independent measures of K, and Km,. If a
significant fraction of the haptens are complexed to
antibody binding sites, then [D] + [T] and the data may
be analyzed by fitting the normalized fluorescence F([T])!
F(0) to the form of Eq. 31 with [D] given by Eq. 6. The
best fit of an experimental curve to this functional form in
theory provides values for the free parameters K, Kmi,
[NM], and F(0) (Fig. 2 a).
Inhibition of bivalent antibody surface
binding by haptens in solution
The evanescently excited fluorescence arising from bound,
intact antibodies is blocked by the presence of high
concentrations of solution hapten. Experimentally, the
concentration of bound antibodies is measured as a
function of the total concentration of hapten in solution
and relative to the fluorescence in the absence of soluble
hapten. In model I, Eqs. 8-11, 13, 17, and 18 imply that
F([T]) [BA2]
F(0) =[BA2]L
E(1 + KJ[D])2 + 8Km2[S] [NB]
-(1 + Kj[D])D(1 + Ks[D])2 + 16Km2[S][NBI]
I[i + 8Km2[S] [NB] - V1 + 16Km2[S][NB]]' (32)
where [D] is given by Eq. 6 with [NM] = 2[NB]. The
normalized fluorescence decreases as a function of [T]
and depends on the values of K, Km2[S], and [NB] (Fig.
2 b).
In model II, antibodies with one antigen binding site
bound to a surface hapten and the other to a soluble
hapten (BDA) are in the following equilibrium
K,[BA][D] = [BDA], (33)
and the total density of surface sites equals
[S] = [A] + [BA] + [BDA] + [BA2]. (34)
Eq. 11 is approximately correct for a large volume/
surface ratio, and together with Eqs. 8-10, 13, 20, 21, 33
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imply that
F([T]) [BA] + [BDA] + [BA2]
F(O) {[BA] + [BDA] + [BA2]10
= [(1 + KJ[D])2 -(Km3[NB])2 + 8Km5[S]Km3[NBI
+ (Km3[NB] -1 -K,S[D]J)
* + Km3[NB] + Ks[D])2 + 16Km5[S]Km3[NB]
* [ - (Km3[NBI)2 + 8Km5[S]Km3[NB]
+ (Km3[NB] - 1)
* V(l + Km3[NB] )2 + 16Km5 [S] Km3[NB] J. (37)
When Km5[S] = 0, Eq. 37 reduces to Eq. 31 with
Kml[NM] = Km3[NB]; and when Km5[S] is large and
Km3[NB] , 0, Eq. 37 reduces to Eq. 32 with Km2 =
Km3Km5. The shape of this function is shown in Fig. 2 d.
FIGURE 2 Theoretical shape of surface fluorescence as a function of
hapten solution concentration. (a) The measured fluorescence as a
function of the total hapten solution concentration [T] for a given
monovalent antibody concentration [NM] decreases to zero according to
Eqs. 31 and 6. For a given solution association constant K, the hapten
concentration at which the fluorescence is halved increases with the
antibody solution concentration [NM] and with the membrane associa-
tion constant Km.. Curves are plotted for KS[NM] = 5 and for
Kml[NM] = 0.1 ( ), 1.0 (-----), 10 ( and 100 (....). The
fluorescence for a bivalent antibody solution concentration [NB] also
decreases with the hapten solution concentration [T]: (b) model I, Eq.
32, KS[NB] = 1.5 and Km2[S] [NB] = 0.01 ( ), 1 (-----), 100(--),
and I04 (....); (c) model II, Eq. 35, KJ[NB] = 1.5, and Km3[NB] =
0.015 and Km4 = 1 ( ), Km3[NB] = 0.015 and Km4 = 100 (-----
Km3[NB] = 1.5 and Km4 = 1(-I---), Km3[NB] = 1.5 and Km4 = 100
(....); (d) model III, Eq. 37, KS[NB] = 1.5 and Km.[NB] = 0.015 and
Km5[S] = 1 ( ), Km.[NB] = 0.015 and Km5[S] = 100 (-----),
Km3[NB] = 1.5 and Km5[S] = 1(I ), Km3[NB] = 1.5 and Km5[S] =
100(....)
and 34 implies that
F([T]) [BA] + [BDA] + [BA2] [1 + Km4 + KS[D]]
F(O) {[BA] + [BDA] + [BA2]}0 1 + Km4 J
1 + (1 + Km4)Km3[NB] 1
-(1 + Kj[D])2 + (1 + Km4 + Ks[D])Km3[NB] J
Substituting Eq. 6 with [NM] = 2[NB] in Eq. 35 gives an
expression for the normalized fluorescence as a function
of Ks, Km3, Km4, [NB], and [T] (Fig. 2 c). When K.4 = 0,
Eq. 35 reduces to Eq. 31 with Kml [NM] = Km3[NB]
In model III, Eqs. 8-11, 13, 20, 24, 33, and
[S] = '/2[A] + '/2[BAI + '/2[BDA] + [BA2] (36)
MATERIALS AND METHODS
Antibodies
Polyclonal murine and sheep IgG (Sigma Chemical Co., St. Louis, MO)
and murine IgG Fab (Jackson ImmunoResearch, Inc., West Grove, PA)
were obtained commercially. The monoclonal murine IgG 1 anti-DNP
antibody ANO2 (Balakrishnan et al., 1982a) was purified from hybri-
doma supernatants by affinity chromatography with protein A-sepharose
4B (Sigma Chemical Co.) (Wright et al., 1988; Anglister et al., 1984).
Binding and elution buffers were 0.05 M Tris(hydroxymethyl)-
aminomethane, 0.01% sodium azide, pH 9.0, and 0.1 M sodium citrate,
0.01% sodium azide, pH 4.5, respectively.
ANO2 Fab fragments were prepared by treating intact ANO2 (1-3
mg/ml) with preactivated (30 min, 370C) papain (Worthington Diagnos-
tics Div., Freehold, NJ) at a 1:100 wt/wt ratio of papain toANO2 for 20
h at 370C in phosphate-buffered saline (PBS; 0.05 M sodium phosphate,
0.15 M sodium chloride, and 0.01S% sodium azide, pH 7.4) with 10 mM
cysteine and 8 mM ethylenediaminetetraacetate. The digestion was
quenched with 20 mM iodoacetamide for 1 h at 0°C. ANO2 Fab
fragments were purified from digestion mixtures by affinity chromatog-
raphy with DNP-conjugated human serum albumin (DNP-HSA, Sigma
Chemical Co.) coupled to sepharose 4B. The washing and elution buffers
were PBS without and with 0.01 M N-2,4-dinitrophenylglycine (DNP-
glycine), respectively. DNP-glycine was removed by extensive dialysis
against PBS. Intact ANO2 antibodies that were sometimes present in
Fab preparations were removed by protein A affinity chromatography.
Fluorescence Labeling
Antibodies were labeled with tetramethylrhodamine isothiocyanate
(Molecular Probes, Inc., Junction City, OR) as described (Mishell and
Shiigi, 1980) and were purified by Sephadex G50-80 chromatography in
PBS followed by DNP-HSA-Sepharose affinity chromatography and
extensive dialysis against PBS. Labeled (R-) antibody concentrations
and the molar ratios of tetramethylrhodamine to antibody (0.1 to 1.0)
were determined spectrophotometrically (Mishell and Shiigi, 1980).
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Gel electrophoresis
Analysis of antibodies with SDS-PAGE was carried out according to
standard methods (Mishell and Shiigi, 1980). Unlabeled and labeled
ANO2 and murine IgG and their Fab fragments ran as appropriate
bands in SDS-PAGE under reducing and nonreducing conditions. No
unreacted tetramethylrhodamine was observed at the dye front when
gels were illuminated with ultraviolet radiation.
Spectrofluorometry
Steady-state fluorescence intensities were measured with a spectrofluo-
rometer (Model 8000C; SLM Instruments, Inc., Urbana, IL). The
relative fluorescence yields of different preparations of labeled antibod-
ies were obtained with the excitation wavelength equal to 514 nm, and
the emitted fluorescence intensity integrated from 530 to 630 nm. The
specificity of labeled and unlabeled intact ANO2 and ANO2 Fab was
confirmed and quantified by spectrofluorometrically monitoring the
fluorescence quenching by DNP-glycine with excitation and emission
wavelengths equal to 280 nm and 340 nm, respectively. Control
experiments were carried out with rhodamine-labeled and unlabeled
polyclonal murine IgG and IgG Fab fragments. Antibody concentra-
tions were 10-30 Mg/ml.
Supported phospholipid monolayers
All water was purified to exceed standards for type I reagent grade
water. Dipalmitoylphosphatidylcholine (DPPC; Calbiochem-Behring
Corp., La Jolla, CA), dinitrophenylaminocaproyldipalmitoyl phosphati-
dylethanolamine (DNP-cap-DPPE; Avanti Polar Lipids Inc., Birming-
ham, AL), and N-(7-nitro-2-1,3-benzoxadiazol-4-yl) dipalmitoylphos-
phatidylethanolamine (NBD-DPPE; Avanti Polar Lipids) were obtained
commercially and were judged to be pure by thin layer chromatography.
Supported planar membranes were prepared by spreading monolayers
of DPPC, DPPC:DNP-cap-DPPE (75:25, mol/mol) or NBD-DPPE:
DPPC:DNP-cap-DPPE (2:75:25, mol/mol) at 100 A2/molecule on the
air/water interface of a Joyce-Loebl Langmuir trough (model 4; Vickers
Instruments, Inc., Malden, MA), compressing the monolayers to a
surface pressure of 35 dyn/cm at 1-2 A2/molecule-min, depositing
single monolayers on fused silica substrates (1 x I' x 1 mm, Quartz
Scientific Inc., Fairport Harbor, OH) treated with octadecyltrichlorosi-
lane (Aldrich Chemical Co., Milwaukee, WI) by vertical dipping at 5
mm/min (Timbs and Thompson, 1990; Wright et al., 1988; von
Tscharner and McConnell, 1981), and transfer to PBS.
Labeled and unlabeled antibodies were prepared for use with sup-
ported monolayers by 0.22 ym filtration and sedimentation at 100,000 g
for 2 h. Supported monolayers containing bound, fluorescently-labeled
antibodies were prepared by treating the monolayers with 100 Ml of 1
mg/ml sheep IgG in PBS for 5 min to block nonspecific binding sites and
then with 200 gl of fluorescently-labeled ANO2 or murine IgG with or
without DNP-glycine and in 1 mg/ml sheep IgG/PBS for 10 min.
Fluorescence microscopy
The fluorescence microscope consisted of an argon ion laser (Innova
90-3; Coherent Inc., Palo Alto, CA), an inverted optical microscope
(Zeiss IM-35, Eastern Microscope Co., Raleigh, NC), and a single-
photon counting photomultiplier (model 31034A; RCA, RCA New
Products Div., Lancaster, PA) interfaced to an IBM PC AT computer
(IBM Instruments Inc., IBM Corp., Danbury, CT), as previously
described (Palmer and Thompson, 1989; Wright et al., 1988). The
fluorescence arising from labeled antibodies on supported phospholipid
monolayers was measured with TIRFM (Axelrod et al., 1984) with
previously described conditions (Poglitsch and Thompson, 1990), except
that the laser power was 1 MW. The concentrations of labeled ANO2
that remained in solution after equilibration with haptenated monolay-
ers were measured with epifluorescence microscopy by focusing the laser
beam to a small spot (-1 Mm3) in the solution -50 gm from the
monolayer surface (Poglitsch and Thompson, 1990). The lateral mobil-
ity of NBD-DPPE in DNP-cap-DPPE/DPPC monolayers was mea-
sured with fluorescence pattern photobleaching recovery (Smith and
McConnell, 1978) as previously described (Wright et al., 1988) except
that the spatial periodicity in the sample plane was 4 gm.
Data analysis
Experimentally determined fluorescence intensities were fit to functional
forms using the Gauss-Newton routine in ASYST software (Macmillan
Software Co., New York, NY). Fluorescence-photobleaching recovery
data were analyzed as previously described (Wright et al., 1988).
Solution association constants were obtained from quenching data by
the following iterative procedure, which is a modification of a previously
published method (McGuigan and Eisen, 1968): (a) the fluorescence
intensities of ANO2, Fa([T]), and polyclonal IgG, Fp([T]), were
corrected for dilution, which occurred during addition of DNP-glycine,
and normalized to maximum values of one; (b) Fp([T]) was fit to Eq. 7
with [D] = [T] and with free parameters (Ks)p and (Qb/Qf)p; (C) to
correct for collisional quenching, Fa([T]) was divided by Eq. 7 with
K = (K.)p, Qb/Qf = (Qb/Qf)p, and [DI = [T] (first iteration) or [D]
equal to the values obtained in step e (subsequent iterations); (d) the
corrected function FA([D]) was fit to Eq. 7 to yield estimates of K, and
Qb/Qf; (e) [D] was estimated for each data point as the difference
between [T] and the product of [NM] and the antibody binding site
fractional occupancy [1 - FA([D])]/[1 - (Qb/Qf)]; (f) steps (c)-(e)
were repeated five times and the best-fit values of K. and Qb/Qf for the
second through fifth iterations were averaged.
RESULTS AND DISCUSSION
Supported phospholipid monolayers
The dependence of the surface pressure on the density of
DPPC monolayers at the air/water interface agreed with
previously published results (von Tscharner et al., 1981;
Phillips and Chapman, 1968). The presence of high-
molar fractions of DNP-cap-DPPE significantly changed
the interfacial pressure-area curve (Fig. 3). DNP-cap-
DPPE/DPPC monolayers labeled with the fluorescent
probe NBD-DPPE appeared uniformly fluorescent within
optical resolution. Fluorescence recovery after photo-
bleaching indicated that l1O% of the fluorescent lipids
were laterally mobile with an apparent diffusion coeffi-
cient 5 x 10- 10 cm2/s.
Solution association constants
The fluorescence of tetramethylrhodamine-labeled and
unlabeled AN02 and AN02 Fab fragments, excited at
280 nm and detected at 340 nm, was quenched by
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FIGURE 3 Interfacial pressure-area isotherms. Shown is the measured relationship of surface pressure to average molecular area during compression
at an air/water interface at 25°C, for DPPC (U) and DNP-cap-DPPE/DPPC (25:75, mol/mol) (*) monolayers.
DNP-glycine, whereas little fluorescence quenching was
observed for unlabeled and labeled murine IgG and its
Fab fragment (Fig. 4). This result is consistent with
previous reports that DNP-glycine quenches ANO2 fluo-
rescence (Leahy et al., 1988; Anglister et al., 1984). The
solution association constants K5 obtained from these data
by the iterative procedure described above were equiva-
lent for labeled and unlabeled intact ANO2 and ANO2
Fab (Table 1), and the average value of K5 = 2.7 ± 0.2
,uM-1 agreed with previous reports (Leahy et al., 1988;
Anglister et al., 1984). The fractional quenching at
saturation, 1 - (Qb/Qf), was significantly less for intact
ANO2 than for Fab fragments, consistent with the
presence of tryptophan residues in the Fc region which are
not effectively quenched.
Antibodies on supported monolayers
The evanescently excited fluorescence of supported mono-
layers treated with 0.1 ,M tetramethylrhodamine-
labeled antibodies (corrected for the relative fluorescence
yields of different antibody preparations) were signifi-
cantly higher for DNP-cap-DPPE/DPPC monolayers
treated with R-ANO2 and R-(ANO2 Fab) than with
R-(murine IgG) and R-(murine IgG Fab), were very low
for DNP-cap-DPPE/DPPC monolayers treated with
R-ANO2 or R-(ANO2 Fab) and high concentrations of
DNP-glycine, and were at background levels for DPPC
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FIGURE 4 Solution equilibrium constants measured by fluorescence
quenching. The fluorescence intensity of unlabeled intact ANO2,
excited at 280 nm and monitored at 340 nm and corrected for dilution
and collisional quenching (see Materials and Methods), is quenched
significantly by DNP-glycine (U). The best fit values of K, and Qb/Qf for
this curve were 2.9 AM ' and 0.39, respectively. Shown also (inset) are
the uncorrected fluorescence intensities for unlabeled intact ANO2 (*)
and murine IgG (A).
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TABLE 1. Solution equilibrium constants of AN02
antibodies determined by fluorescence quenching
Antibody K. Qb/Qf
mU-'
ANO2 2.8 ± 0.2 0.41 ± 0.01
R-ANO2 3.0 ± 0.3 0.47 ± 0.02
ANO2 Fab 2.1 ± 0.1 0.28 ± 0.02
R-(ANO2 Fab) 2.8 ± 0.8 0.19 ± 0.02
Average 2.7 ± 0.2
Shown are the solution association constants K, determined from the
quenching of ANO2 ultraviolet fluorescence by DNP-glycine. Each
value is the mean and standard deviation of the values obtained from
three independent ANO2 quenching curves. Each ANO2 quenching
curve was corrected for collisional quenching using the average of two
curves for the appropriate murine IgG (labeled or unlabeled, intact or
Fab).
monolayers treated with R-ANO2 and R-(ANO2 Fab)
(data not shown). These results strongly suggest that
intact R-ANO2 and R-(ANO2 Fab) specifically bind to
DNP-cap-DPPE in DPPC monolayers. DNP-cap-DPPE/
DPPC supported monolayers containing bound R-ANO2
and R-(ANO2 Fab) appeared uniformly fluorescent within
optical resolution.
Adsorption time for antibodies at
supported monolayers
The evanescently excited fluorescence of R-ANO2 and
R-(ANO2 Fab) on DNP-cap-DPPE/DPPC monolayers
remained constant for times > 10 min and < 1 or 2 h
(data not shown). This observation is consistent with
previous reports that the density of antibodies bound to
other model membrane surfaces is approximately con-
stant after several minutes (Darst et al., 1988; Nygren et
al., 1987; Petrossian and Owicki, 1984), suggests that the
interaction between solution antibodies and surface hap-
tens rapidly approaches a steady state if not equilibrium,
and supports the use of equilibrium expressions in subse-
quent analysis. Very slow increases in antibody surface
densities after very long times have been reported in
similar model systems (Darst et al., 1988; Nygren et al.,
1987; Uzgirus and Kornberg, 1983) and may also occur
for ANO2 antibodies on dinitrophenylated monolayers.
Accuracy of concentration determinations
Previous work has shown that the fluorescence excited by
the evanescent field is proportional to the surface density
of fluorophores up to at least 14,000 molecules/Mm2 (Lok
et al., 1983a; Lok et al., 1983b), which is well above the
estimated antibody surface density at saturation in this
work (see below). Solution measurements indicated that
saturating amounts (10-100 ,M) of DNP-glycine did not
affect the intensity of tetramethylrhodamine fluorescence
of labeled ANO2 antibodies, in contrast to similar mea-
surements on fluorescein-labeled anti-DNP IgE (Erick-
son et al., 1987). Thus, the fluorescence measured with
TIRFM should be proportional to the antibody surface
density.
To determine if the antibody concentrations in solu-
tions adjacent to supported monolayers were equal to the
applied concentrations, the fluorescence excited with a
laser beam tightly focused in the solution adjacent to
antibody-treated supported monolayers was measured.
These measurements, calibrated with solutions of known
antibody concentrations, indicated that the average solu-
tion concentration depletion for applied antibody concen-
trations was - 7% and that very little depletion occurred
at higher applied antibody concentrations. This result is
consistent with the number of antibodies applied and the
estimated antibody surface densities (see below). In
addition, an average of -90% of R-ANO2 and R-(ANO2
Fab) prepared for application to supported monolayers
could be readsorbed to DNP-HSA Sepharose 4B and
recovered, indicating that a very high fraction of the
labeled antibodies retained binding activity for DNP.
Thus, the solution concentrations of active antibodies
adjacent to the supported monolayers were nearly equal
to the applied antibody concentrations.
Fab surface density as a function of
Fab solution concentration
The evanescently excited fluorescence of R-(ANO2 Fab)
on DNP-cap-DPPE/DPPC monolayers as a function of
the Fab solution concentration had the general appear-
ance of a conventional saturation curve, whereas the
fluorescence on DPPC monolayers was signficantly lower
and was linear with Fab concentration (Fig. 5). The
fluorescence on DPPC monolayers was attributed to
R-(ANO2 Fab) within the evanescent field but not bound
to the surface. The best fit to Eq. 16 of the difference in
the measured fluorescence for DNP-cap-DPPE/DPPC
and DPPC monolayers, normalized to a maximum value
of one, yielded Km, = 0.31 AiM-M and F(oo) = 1.2.
The measured association constant Km, for R-(ANO2
Fab) with surface haptens was a factor of nine smaller
than the measured association constant K8 for R-(ANO2
Fab) with soluble haptens. Similar differences between
solution and surface association constants have been
reported for other antibodies (Darst et al., 1988). The
discrepancy may reflect the different covalent attach-
ments of the dinitrophenyl moiety to the soluble and
surface carrier molecules (glycine and phosphatidyletha-
nolamine). Solution association constants of ANO2 with
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FIGURE 5 R-(AN02 Fab) binding to DNP-cap-DPPE/DPPC mono-
layers. The difference (U) of the evanescently excited fluorescence of
R-(AN02 Fab) on DNP-cap-DPPE/DPPC (v) and DPPC (*) sup-
ported phospholipid monolayers increased with the R-(AN02 Fab)
solution concentration and is compared to the best fit to Eq. 16.
different DNP conjugates can vary within a factor of at
least 20 (Leahy et al., 1988).
The lower association constant for surface DNP could
also arise from repulsive (including steric) interactions
among surface-bound Fabs (Tamm and Bartoldus 1988b)
or from unfavorable orientations of surface-associated
DNP (Stanton et al., 1984; Balakrishnan et al., 1982b).
For a simple model in which antibody binding sites are
equilibrated between accessible (A) and inaccessible (I)
states with association constant
Ka = [I]/[A], (38)
binding and competition curves are given by Eqs. 16 and
31 with Kmi replaced by an apparent association constant
Ka 1, where
Ka Km, (39)ml = I + Ka
(derivation not shown). If this simple model were to
account entirely for the difference between solution and
surface haptens, then Eq. 39 implies that Ka m 8 and that
most of the surface haptens are not antibody accessible.
Surface density of Intact antibodies
as a function of solution concentration
The fluorescence of intact R-ANO2 on DNP-cap-DPPE/
DPPC and DPPC supported monolayers as a function of
the R-ANO2 solution concentration also reached an
apparent saturation (Fig. 6). The apparent association
constant of R-ANO2 on DNP-cap-DPPE/DPPC mono-
layers was - 3 uM-', which is 10-fold higher than that of
R-(ANO2 Fab) and similar in value to that measured by
conventional assay with separation of bound and free
species for ANO2 on fluidlike (- 8 uM-'; Wright et al.,
1988) and solidlike (- 3 uM-'; Timbs and Thompson,
1990) supported planar membranes.
The binding curve for R-ANO2 was corrected for the
fluorescence on DPPC monolayers, normalized to a maxi-
mum value of one, and fit to the functional forms of the
theoretical expressions for the three different models of
bivalent surface attachment. The best fit to Eq. 19 (model
I) yielded 2Km2[S] = 1.8 ,uM-' and F(oo) = 1.2, and the
best fit to Eq. 23 (model II) yielded Km3(1 + Km4) = 3.2
AM-1 and F(o) = 1.0. The data could not be fit to the
functional form of model III (Eq. 26) with Km3, Km5[S],
and F(oo) as free parameters. Therefore, the data were fit
to this functional form with Km5 [S] fixed (sequentially) at
different values and with Km3 and F(o) as free parame-
ters. Fig. 7 shows the values of Km3, F(oo), and x2 for
different values of Km5[S]. The data have three regions:
when Km5[SI c 0.1 (monovalent binding), Km3 = 3 ,uM'-,
F(oo) = 1.0, and x2 is low, when 0.1 s Km5[S] < 100
(heterogeneous binding), Km3 ranges from 3 ,AM-' to 0.01
AM-', F(oo) ranges from 1.0 to 2.4, and x2 is high; and
when Km5[S] > 100 (bivalent binding), 2 Km3Kmi5[SI
1.8 /LM-1, Km3 is very small, F(o) = 2.4, and x2 is low.
This analysis indicates that either (a) the antibodies
bind primarily in a monovalent manner, but the associa-
tion constant of the first antigen binding site is 10-fold
larger than that of a sinzle Fab fragment; (b) the
association constant for a single binding site of the intact
antibodies is approximately equal to that of Fab frag-
ments and the constant that describes the equilibrium
between antibodies bound by one and two sites is near
unity (Km5[S] = 4); or (c) the association constants for the
first and second binding events are very low and high,
respectively. If Km3 equals the measured value of Km,,
analysis according to model II implies Km4 = 9 and
according to model III implies 2Km5[S] = 8, and the
calculations in Fig. 1 c imply that, at most antibody
surface densities, 50-90% of the bound antibodies are
linked to the membrane by two sites. This result is
consistent with previous efforts to determine the valency
of antibody attachment on phospholipid surfaces (Parce
et al., 1979).
Maximum antibody surface densities
The ratio r of the fluorescence intensities of DNP-cap-
DPPE/DPPC and DPPC monolayers treated with la-
beled antibodies is, in the absence of nonspecific surface
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FIGURE 6 Intact R-AN02 binding to DNP-cap-DPPE/DPPC monolayers. The difference (U) of the evanescently excited fluorescence of R-AN02
on DNP-cap-DPPE/DPPC (-) and DPPC (*) supported phospholipid monolayers increased with the R-AN02 solution concentration. The data are
compared to the best fits to the following theoretical forms: Eq. 19 and Eq. 26 with large (fixed) Kin[S] (-); Eq. 23 and Eq. 26 with K.5[S] = 0
.(.* ); Eq. 26 with Kn5[S] = 4.0 ( ).
adsorption,
[SI]+d[N] (0
d[N] ' (4)
5 where d is the evanescent field depth (: 900 A) and [N]
denotes [NM] or [NB]. The measured value of r was - 12
for [N] = 10 ,uM, which implies an antibody surface site
4 /4 density [S] 6,000 molecules/,gm2. This value is consis-
. < | tent with antibody size and is in reasonable agreement
3 _- - tX -3 0 3_ with previous measurements (Wright et al., 1988; Uz-\LOGto Km5 [SI giris, 1986).
M'2
Inhibition of AN02 Fab and intact
e | < AN02 surface binding by
DNP-glycine
The evanescently excited fluorescence of DNP-cap-DPPE/
0-3 -2 -1 0 3 DPPC monolayers treated with R-(ANO2 Fab) or
LOG10 Km5(S] R-ANO2 decreased to the measured fluorescence on
DPPC monolayers with increasing concentrations of DNP-
FIGURE 7 Dependence of Km3 on Km4[S]. The best fits of the data in glycine in solution and with DNP-glycine half concentra-
Fig. 6 to Eq. 26 with fixed, increasing values of Kin[S] produce tions of =e1 ,uM. Solution measurements indicated that
decreasing values of Km3 (-) and increasing values of F(oo) (). DNP-glycine at concentrations < 100 ,uM did not signifi-
Chi-squared (A, inset) is smaller for lower and higher values of Km, [S]. cantly quench the tetramethylrhodamine fluorescence of
Pisarchick and Thompson Antibodies on Supported Phospholipid Monolayers 1 245Pisarchick Thompson Supported Phospholipid Monolayers
1.0O
0.8
w
Z 0.6
w
U)
w
0
D 0.4
LL
0.2
-1o -8 -6 -4 -2
LOGo0 [DNP-GLYCINE]
FIGURE 8 Inhibition of R-(ANO2 Fab) binding to DNP-cap-DPPE/DPPC monolayers by DNP-glycine. The evanescently excited fluorescence (U)
of 2.0MuM R-(ANO2 Fab) on DNP-cap-DPPE/DPPC supported monolayers decreased with the solution concentration of DNP-glycine. Shown also is
Eq. 31 with K,= 2.7 gM-', [NM] = 2.0MM, and Km, =0( ), 0.31 uMM' (-----) and 3.1 SM-M (.... ).
labeled polyclonal IgG or ANO2 and, therefore, should-
not have affected the proportionality of the measured
fluorescence to the antibody surface density.
The fluorescence of R-(ANO2 Fab) on DNP-cap-
DPPE/DPPC monolayers as a function of the solution
concentration of DNP-glycine was corrected for the
fluorescence measured on DPPC monolayers in the ab-
sence of DNP-glycine and normalized to a maximum
value of one (Fig. 8). The data were fit to the functional
form of Eq. 31 with [D] given by Eq. 6. The best fit with
K5 and [NM] set equal to their known values yielded a very
low value for Km, (% 0). However, the data also agreed
well with Eq. 31 when Km, equaled its independently
measured value of 0.31 ,M'- but did not agree well with
Eq. 31 when Km, equaled 3 ,uM-'. The data, therefore,
support but do not independently confirm the measured
value of Kmi.
The fluorescence of R-ANO2 on DNP-cap-DPPE/
DPPC monolayers also decreased with the solution concen-
tration of DNP-glycine. The corrected data were com-
pared with the functional form of Eq. 37 with Km5[S]
fixed sequentially as for the direct binding curve (above),
Km3 fixed at the best-fit values for the given value of
Km5[S] shown in Fig. 7, and K, and [NB] equal to their
experimentally determined values. The analysis showed
that the data were consistent with, but could not distin-
guish among, the full range of pairs of Km3 and Km5 [S]
values (Fig. 9).
Limitations of the theoretical models
Although the simple theoretical models outlined in this
work provide adequate data description, several phenom-
ena that may be important in the antibody surface
association have not been included. First, the mechanisms
simplify possible multistep association reactions between
single hapten binding sites and haptens (Pecht, 1982;
Pecht and Lancet, 1977). Second, attractive or repulsive
interactions among monolayer-bound antibodies or anti-
body-phospholipid complexes that lead to submicroscopic
antibody oligomers (Wright et al., 1988), ordered anti-
body arrays (Uzgiris and Kornberg, 1983), or steric
effects (Tamm and Bartoldus, 1988b) could alter appar-
ent antibody surface association constants. Third, submi-
croscopic coexistent fluid and solid domains in the sup-
ported monolayers (McConnell et al., 1984; Seul et al.,
1985) in which surface haptens have different antibody
accessibilities (Balakrishnan et al., 1982b) would result in
heterogeneous surface association constants.
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FIGURE 9 Inhibition of intact R-ANO2 binding to DNP-cap-DPPE/DPPC monolayers by DNP-glycine. The evanescently excited fluorescence (U)
of 0.5 ,M R-ANO2 on DNP-cap-DPPE/DPPC supported monolayers decreased with the solution concentration of DNP-glycine. Shown also is Eq.
37 with K, = 2.7 M-' and Kms[S] = 0, Km3 = 3.2 M-' (... ); K.5[S] = 4, Km3 = 0.33 M-' (-); and Kin[S] = 500, Km3 = 0.0018 M-'
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SUMMARY
This work has shown that TIRFM can be used to
investigate the association of fluorescently-labeled ligands
at specific surface sites on supported planar model mem-
branes. One of the key features of the model system is the
use of supported membranes, which are unusually resis-
tant to nonspecific protein adsorption. Another advantage
of TIRFM for examining surface binding equilibria is
that separation of bound and free states is not required,
and the technique may be used to measure weak binding
constants. The lower limit for measurable association
constants is determined primarily by the ratio of bound
species to those that are not bound but within the
evanescent field and depends on the association constant,
the evanescent field depth, the maximum surface site
density, and the amount of nonspecific binding (Poglitsch
and Thompson, 1990; Thompson et al., 1988). The data in
Fig. 5 demonstrate that TIRFM can be used to measure
association constants as low as -0.3 gM-1 when the
surface site density is -6,000 molecules/MAm2.
The association constant for the Fab fragment of the
anti-DNP monoclonal antibody ANO2 with DNP-cap-
DPPE in planar membranes, measured with TIRFM, was
-10-fold smaller than the association constant of ANO2
Fab with DNP-glycine in solution, which suggests that
the geometry of Fab-hapten interactions may signifi-
cantly affect equilibrium parameters. In addition, the
apparent association constant for intact ANO2 with
planar membranes containing DNP-cap-DPPE, mea-
sured with TIRFM, was only -10-fold higher than that of
the ANO2 Fab fragments. This result does not depend on
assumed theoretical binding mechanisms and conflicts
with the notion that a primary biological function of
antibody bivalency is to dramatically increase membrane
association constants. In addition, analysis of these data
with simple theoretical models suggests that, at equilib-
rium, only 50-90% of the intact ANO2 bound to planar
membranes are attached by two-antigen binding regions.
Future investigations should provide a more thorough
understanding of the relationship between antibody and
membrane properties to the equilibrium between monova-
lent and bivalent attachment; and of the relationship
between this equilibrium and the lateral (Wright et al.,
1988) and rotational (Timbs and Thompson, 1990) mobil-
ities of bound antibodies. The work described herein is
also a prerequisite to combining TIRFM with fluores-
cence photobleaching recovery (Burghardt and Axelrod,
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1981) or correlation spectroscopy (Thompson and Axel-
rod, 1983) to obtain kinetic information.
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